60
Participants
Start Date
November 24, 2021
Primary Completion Date
July 23, 2024
Study Completion Date
July 23, 2024
Vancomycin Pre-Treatment
Four times daily dosing with Vancomycin
Vancomycin Placebo
Four times daily dosing with Vancomycin Placebo
SER-155
Once daily dosing with SER-155
SER-155 Placebo
Once daily dosing with SER-155 placebo
Memorial Sloan Kettering Cancer Center, New York
Georgetown (MedStar Health), Washington D.C.
University of North Carolina Chapel Hill, Chapel Hill
Mayo Clinic - Jacksonville, Jacksonville
University of Florida - Division of Hematology & Oncology, Gainesville
Mayo Clinic - Rochester, Rochester
University of Chicago Medical Center, Chicago
Banner Health - MD Anderson Medical Center, Gilbert
Mayo Clinic - Scottsdale, Scottsdale
University of California, Los Angeles - Division of Hematology-Oncology, Marina del Rey
City of Hope, Duarte
Fred Hutchinson Cancer Research Center, Seattle
Harvard Medical School - Massachusetts General Hospital Cancer Center, Boston
Memorial Sloan Kettering Cancer Center
OTHER
Seres Therapeutics, Inc.
INDUSTRY